Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Avid Bioservices, Inc.

Avid Bioservices is a drug substance CDMO that offers full lifecycle capabilities, providing services from concept to commercial supply in mammalian cell culture for clinical and commercial biologics.

msh id	COM:AVIDBIO
symbol	CDMO
name	Avid Bioservices, Inc.
homepage url	https://www.avidbio.com
country	US
sector	Healthcare
industry	Biotechnology
market	STOCKS
employee count	371
crunchbase url	-
linkedin url	-
founders	-

market cap	469.86M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.4
growth cost of revenue	0.42
growth depreciation and amortization	0.61
growth ebitda	-0.7
growth ebitda ratio	-0.76
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-0.14
growth gross profit ratio	-0.31

COM:AVIDBIO

Avid Bioservices

Last Close

12.22

21/11 21:00

Market Cap

469.86M

Beta: -

Volume Today

2.41M

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	145.67M
cost of revenue	145.67M
depreciation and amortization	7.21M
ebitda	4.6M
ebitda ratio	0.03
eps	0.01
eps diluted	0.01
operating expenses	27.88M
operating income	-2.61M
operating income ratio	-0.02

accounts receivables	2.25M
capital expenditure	-77.64M
cash at beginning of period	126.52M
cash at end of period	38.89M
inventory	43.91M
working capital ttm	27.27M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-